000 | 01650 a2200517 4500 | ||
---|---|---|---|
005 | 20250513110445.0 | ||
264 | 0 | _c19970130 | |
008 | 199701s 0 0 eng d | ||
022 | _a0007-1048 | ||
024 | 7 |
_a10.1046/j.1365-2141.1996.d01-1943.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMathiot, C | |
245 | 0 | 0 |
_aSoluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). _h[electronic resource] |
260 |
_bBritish journal of haematology _cDec 1996 |
||
300 |
_a660-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Myeloma _xdiagnosis |
650 | 0 | 4 |
_aParaproteinemias _xdiagnosis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptors, IgG _xblood |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aMary, J Y | |
700 | 1 | _aTartour, E | |
700 | 1 | _aFacon, T | |
700 | 1 | _aMonconduit, M | |
700 | 1 | _aGrosbois, B | |
700 | 1 | _aPollet, J P | |
700 | 1 | _aMichaux, J L | |
700 | 1 | _aEuller Ziegler, L | |
700 | 1 | _aSautès, C | |
700 | 1 | _aBataille, R | |
700 | 1 | _aFridman, W H | |
773 | 0 |
_tBritish journal of haematology _gvol. 95 _gno. 4 _gp. 660-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2141.1996.d01-1943.x _zAvailable from publisher's website |
999 |
_c8973519 _d8973519 |